Literature DB >> 3690354

Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.

K J Kellar1, P J Whitehouse, A M Martino-Barrows, K Marcus, D L Price.   

Abstract

The total population of muscarinic receptors and a subpopulation of muscarinic receptors with high affinity for agonists were measured with [3H]quinuclidinyl benzilate and [3H]acetylcholine, respectively, in homogenates of cerebral cortex from control and Alzheimer's disease brains. No significant differences between control and Alzheimer's diseased cortex were found in either the total population of receptors or the subpopulation with high affinity for agonists in either the frontal or temporal poles. Nicotinic cholinergic receptors labeled by [3H]acetylcholine were measured in homogenates and by autoradiography in the same brain areas. In contrast to muscarinic sites, binding to nicotinic sites was markedly decreased in Alzheimer's disease cortex. Autoradiography of [3H]acetylcholine binding to nicotinic sites indicated that in control cortex these sites are more concentrated in laminae IV-VI than in the superficial laminae, and that in Alzheimer's disease there is loss of these sites in all cortical laminae.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3690354     DOI: 10.1016/0006-8993(87)91556-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  32 in total

1.  Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

Authors:  E D London; M J Ball; S B Waller
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

2.  Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration.

Authors:  S W Rogers; L C Gahring; A C Collins; M Marks
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

3.  Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD.

Authors:  Mattis B Wigestrand; Yann S Mineur; Christopher J Heath; Frode Fonnum; Marina R Picciotto; Sven Ivar Walaas
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

Review 4.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.

Authors:  J J Claus; E A Dubois; J Booij; J Habraken; J C de Munck; M van Herk; B Verbeeten; E A van Royen
Journal:  Eur J Nucl Med       Date:  1997-06

6.  Laminar distribution of the multiple opioid receptors in the human cerebral cortex.

Authors:  J M Hiller; L Q Fan
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

7.  Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors.

Authors:  Gregory P Hussmann; Robert P Yasuda; Yingxian Xiao; Barry B Wolfe; Kenneth J Kellar
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 8.  The dendritic hypothesis for Alzheimer's disease pathophysiology.

Authors:  J Nicholas Cochran; Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2013-12-12       Impact factor: 4.077

9.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

Review 10.  Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.

Authors:  Sofia Jürgensen; Sergio T Ferreira
Journal:  J Mol Neurosci       Date:  2009-08-19       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.